Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.64898/2026.10.02.756329

Desktop iDMS: A stand-alone application of intelligent differential mobility spectrometry (iDMS), a neural net-work that predicts optimal separation and compensa-tion voltages for field asymmetric differential ion mobil-ity spectrometry

Nguyen-Tran, T.·Hashimoto-Roth, E.·Shi, X.-X.·Organ, M. G.·Perkins, T. J.·Lavallee-Adam, M.·Bennett, S. A. L.
View original source ↗Export metadata ↓

Abstract

Summary: Mass spectrometry resolution of glycosphingolipids requires advanced separation methods. The virtual-ly identical structures of glycolipid epimers cannot be discriminated by routine multiple reaction monitoring-high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry (MRM-LC-ESI-MS/MS). Sep-aration can be achieved using field asymmetric (differential) ion mobility mass spectrometry (FAIMS/DMS). A major bottleneck to MRM-LC-ESI-DMS-MS/MS method development lies in manually optimizing the compound-dependent parameters of separation voltage (SV) and compensation voltage (CoV). To address this challenge, we developed intelligent Differential Mobility Spectrometry (iDMS). iDMS is a supervised deep neural network that evaluates and predicts the optimal ion mobility SV and CoV parameters for any user-requested monoglycosphingolipid from a training set of measured signal intensities composed of 12 lipids (6 stereoisomer pairs). We initially introduced iDMS as a series of python scripts. Here, we share desktop applications of both iDMS and its pre-processing input data assembly modules (DMS Data Extraction Toolkit). Both software assemblies enable users to rapidly deploy a validated machine learning alternative to manual DMS optimization. The applications are user-friendly, operate with-out need for any technical operating environment, make training dataset assembly quick and simple, and return measured, normalized, and predicted ionograms at every user-interrogated SV, evaluation of separability at each SV and CoV combination, and prediction of optimal resolution parameters to accelerate users MRM-LC-ESI-DMS-MS/MS deployment. Availability and implementation: Desktop iDMS and DMS Data Extraction Toolkit are native desktop applications for macOS (Apple Silicon), freely available for download at https://www.neurolipidomics.com/platforms.html under the GNU v3.0 license. The source code is available from GitHub and Zenodo at https://github.com/Neurolipidomics/iDMS, https://zenodo.org/records/22214408, https://github.com/Neurolipidomics/DMSDataExtractionToolkit, and https://zenodo.org/records/22777403. Bench-marking metrics are available at https://www.biorxiv.org/content/10.64898/2026.08.26.747394v1.

Explore related subjects

bioinformaticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Nguyen-Tran, T., Hashimoto-Roth, E., Shi, X.-X., Organ, M. G., Perkins, T. J., Lavallee-Adam, M., Bennett, S. A. L.. 2026-10-07. Desktop iDMS: A stand-alone application of intelligent differential mobility spectrometry (iDMS), a neural net-work that predicts optimal separation and compensa-tion voltages for field asymmetric differential ion mobil-ity spectrometry. https://doi.org/10.64898/2026.10.02.756329

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Carrier-Limited Release Risk in Electrospun Nanofibers for Regenerative Endodontics: Constraint Discovery from 25 Formulations

Regenerative endodontics needs an intracanal carrier that keeps disinfecting across a dressing interval that clinicians schedule at one to four weeks, without harming the stem cells that rebuild the pulp. We ask what one completed 25-formulation electrospinning campaign of poly(vinylpyrrolidone) (PVP) fibers carrying metronidazole, ciprofloxacin, minocycline and Ca(OH)2 can decide, and use machine learning for constraint discovery and decision support rather than as a new predictor. After an audit against the source thesis, logistic regression predicts fine-fiber formation at 96% leave-one-out accuracy, but a one-threshold rule does as well, the gain over the 80% majority baseline is not significant (exact McNemar p = 0.125), and accuracy falls to 84% when mixture loading is encoded per component. Diameter models interpolate within formulation families (ridge MAE 193 nm, 95% CI 96 to 317 nm) and fail across them (R^2 < 0). Because the campaign never measured release, we assemble a same-drug, cross-carrier evidence table: 17 bounded metronidazole and ciprofloxacin observations from seven studies, with two-sided censoring. Water-soluble carriers (PVP, PVA) completed release within 80 h (PVP within 8 h); no water-insoluble monolithic carrier reached 90% within its observation window, releasing 1.5 to 50%; both within-study comparisons separate at matched loading; and blend, core-shell and thick-mat architectures released over 3 to 28 days. The PVP mats therefore carry a carrier-limited release risk, not a proven ceiling, and one dissolution experiment can confirm or overturn it. A censoring-aware screen keeps three necessarily and one possibly nondominated formulation, and fixed-budget replays show that uncertainty sampling finds failed formulations sooner, except the one it is confidently wrong about.

bioinformatics↗
bioRxiv2026

CellMethMarker provides an integrated database of human cell- and tissue-type-specific DNA methylation markers

Cell- and tissue-type-specific DNA methylation markers provide epigenetic signatures of cellular identity and are widely used to infer cellular origin from bulk and single-cell methylomes. Existing resources mainly emphasize disease-associated biomarkers, methylome atlases, genomic annotations or RNA-based cell markers, leaving an unmet need for an integrated region-level resource dedicated to such markers. Here we present CellMethMarker (http://gu-zhanglab.hfcas.ac.cn/CellMethMarker), a curated database integrating 347,514 de novo markers derived from uniformly processed whole-genome and reduced-representation bisulfite sequencing datasets, 2,203,507 literature-derived marker records and harmonized metadata for 2,810 samples. CellMethMarker enables cell- and tissue-centered marker retrieval, coordinate-based search, genome-browser visualization, interactive methylation analysis and data download. In an independent single-cell methylome atlas, these markers recover the expected cell-type-associated methylation patterns, and a platform-matched reference built from them lowers the mean deconvolution error from 0.365 to 0.144. CellMethMarker therefore links region-level DNA methylation variation to cellular identity and supports methylome-based cell-type annotation and deconvolution.

bioinformatics↗
bioRxiv2026

IG-28 enables identification and quantification of high-confidence isoforms from large bulk and single-cell full-length cDNA datasets

The technology to sequence full-length transcriptomes from bulk and single-cell samples has rapidly advanced. As a result, full-length cDNA datasets now reach billions of reads in size which is beyond the capability of most established isoform identification tools. Here, we introduce IG-28 which addresses this challenge with its capability to process and analyze large fl-cDNA datasets fast and using minimal computational resources. In contrast to its predecessor Mandalorion, IG-28 is not limited to bulk fl-cDNA but is capable of parsing, processing, and analyzing single-cell fl-cDNA datasets. It does so in a lightweight, flexible manner, integrating seamlessly with established scRNA-seq analysis workflows. We benchmarked IG-28 against a variety of established and new isoform identification tools using several bulk and a complex single-cell fl-cDNA dataset and found that IG-28 consistently outperformed the other tools by identifying high-confidence public isoforms.

bioinformatics↗